Clinical Trial: A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07837622) titled 'A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors' on Sept. 18.

Brief Summary: This study is a single-arm, open-label, multicenter, non-randomized phase IIa/IIb clinical study to evaluate the efficacy and safety of BL-M09D1 for injection in patients with locally advanced or metastatic urothelial carcinoma and other solid tumors.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Urothelial Carcinoma (UC) Solid Tumors

Intervention: DRUG: BL-M09D1

Administration by intravenous infusion for a cycle of 3 weeks.

Recruitment Status: NOT_YET_RECRUITING...